SlideShare a Scribd company logo
1 of 36
Download to read offline
Merck KGaA
Darmstadt, Germany
Lenaig Savary, Senior Biomanufacturing Engineer
Scaling Strategies with
stirred single-use
bioreactors from bench
to clinical scale
Application to Mobius® Bioreactors from 2 L to 2000 L
01
02
03
Agenda
2
General Principles
Key Engineering Parameters – Scaling
Strategies
Application to the Mobius® Bioreactors
from 2 L to 2000 L
Scaling Strategies with Stirred Single-use Bioreactors
No Linear Factors in Scaling Up
As surface area
increases, process
volume and process
complexity also
increase.
Surface Area
Single Cell
Shake Flask Bioreactor
Complexity
Scale-up
General Principles
Influencing Factors
Biological Factors Chemical Factors Physical Factors
Number of generations
Mutation probability
Contamination vulnerability
pH control agents
Medium quality
Water quality
Medium sterilization
Foam formation due to
surface tension changes
Tank configuration
Aeration (O2 supply, CO2
stripping, shear stress)
Agitation (homogenization
and shear stress)
Back pressure and
hydrostatic pressure
Temperature control and
heat transfer
Reference: M. Levin. Pharmaceutical Process Scale Up. 2nd Edition Taylor & Francis 2006
Scale-Up and Process Transfer
General Principles
Agitation and aeration
▪ Bulk liquid mixing and shear stress
→ Agitation
▪ Oxygen transfer and pCO2 removal
→ Aeration
Parameters that can be used for scale-up include:
• Geometric similarity—impeller design
• Mixing time—Reynolds number
• Tip speed (~ shear)
• Power input per volume (P/V)
• Oxygen mass transfer coefficient (kLa)
Ensuring circulation of nutrients, dissolved gasses and removing
metabolites is important in bioreactors
The most important criteria is mixing. Mixing is more difficult as scale increases.
Scaling Strategies with Single-use STR
Impossible to Keep All Scale-up Criteria Constant
Mixing time
Tip speed
(shear stress)
Power input per volume (P/V)
Oxygen mass transfer
coefficient KLa
Geometric similarity
It is critical to characterize key engineering parameters
and identify a relevant scaling factor according to bioreactor design.
01
02
03
Agenda
7
General Principles
Key Engineering Parameters – Scaling
Strategies
Application to the Mobius® Bioreactors
from 2 L to 2000 L
 Vessel height to vessel diameter (H/D)
typically between 1:1 and 2:1
 Impeller diameter to vessel
diameter (Dimp/D)
50 L 200 L
H
D
Dimp
1000 L3 L
Keeping constant ratio in dimension
of bioreactors across the scales
Geometric Similarity
Scaling Strategies with Stirred Single-use Bioreactors
Reynolds Number
Dimensionless number to predict flow patterns
in turbulent conditions = Re > 10,000
Why is mixing a critical parameter ?
 Even distribution of nutrients,
 Minimizing waste concentration,
 Control of pH, DO and Temperature,
 Minimizing shear stress (impeller / fluid
dynamics)
 Proper mixing is more challenging at larger
scales than smaller scales
Scaling Strategies with Stirred Single-use Bioreactors
Mixing Time and Reynolds Number
𝑹𝒆 =
𝝆𝑵𝑫 𝟐
𝝁
Where ρ = Fluid density
N = Impeller agitation Rate
D = Impeller diameter
μ = Fluid dynamic viscosity
 Based on a cylindrical tank design with centered rotating impeller
 Does not take into account impeller design
Mixing Times: compare like for like !
Mixing time is empirically determined by the
decolorization method or the conductivity
method
Laminar flow
Re < 10
Transition field
10 < re < 104
Turbulent flow
104 < Re
Scaling Strategies with Stirred Single-use Bioreactors
Tip Speed (m/s)
▪ Criteria for shear force is typically 2 m/s maximum.
▪ The highest shear zones in a stirred-tank bioreactor are
often described as existing within the impeller zone.
Because the outer edges of the impeller blades create
shear as they rotate through the liquid, the impeller tip
speed is often considered during bioreactor comparisons:
𝑻𝒊𝒑 𝑺𝒑𝒆𝒆𝒅 = 𝝅 ∙ 𝑫 ∙ 𝑵
Where D = Impeller diameter
N = Impeller agitation rate
0.000
0.200
0.400
0.600
0.800
1.000
1.200
1.400
1.600
1.800
20 40 60 80 100120140160180200220240260280300320340360380400
TipSpeed(m/s)
RPM
Mobius® Bioreactor Tip Speed
Calculations
3L CellReady
50L CellReady
200L CellReady
Tip speed calculation does not take into account impeller design.
3 L
50 L
200 L
Power Input per Volume (P/V)
Scaling Strategies with Stirred Single-use Bioreactors
𝑃𝑜
𝑉
= 𝑁 𝑃 ∙ 𝜌 ∙ 𝑁3
∙ 𝐷5
Where Po = Ungassed power input
V = Liquid working volume
Np = Impeller power number
ρ = Fluid density
N = Impeller agitation rate
D = Impeller diameter 200 L Mobius® Bioreactor with bottom-mounted impeller
Choosing an agitation rate that matches energy
dissipation rate or power per unit volume (W/m3) is
a common approach.
Impeller design, fluid density, and agitation
rate are considered in the ungassed power per unit
volume (Po/V) equation
Reference: Xing Zizhuo et al. Biotechnology and Bioengineering, Vol 103, 2009. Stephen
Kaiser et al. Computational Fluid Dynamics Technologies and Applications, InTech, 2011
Using this scaling method, agitation rate is varied to maintain
similar ungassed power per unit volume across vessels and working volumes.
40 L
200 L
Easy
calculation
of P/V
Power Input Per Volume (P/V)
 Working volume
range
 Impeller always
immersed
Scaling Strategies with Single-use STR
Oxygen Mass Transfer Coefficient (kLa) and Oxygen Uptake Rate
 Physical kLa are determined for various Power/Volume (P/V) and gas flow rates (vvm) using the static gassing out
method:
kLa = Oxygen Transfer Rate / DO saturation concentration = OTR/C*
 Biological kLa depends on the clone and maximum viable cell concentration :
kLa BIO = Oxygen Uptake Rate / DO saturation concentration = OURmax/C*=(QO2 max). VCCmax /C*
• A-mAb case study[4] at 15.106 cells/mL with OUR of 1.5 mmol/L.h → kLa = 7 h-1
 Typical kLa for animal cell culture below 20.106 cells/mL : 1-10 h-1
Not always known!
To prevent hypoxia (oxygen limitation), available kLa for a bioreactor design
should be superior to the biological kLa demand of cell lines in culture. kLa > kLa BIO
[4] A-mab, a case study in Bioprocess Development, CMC Biotech working group 2009
Sufficient O2/Air delivery is required not only to support cell growth, metabolism and protein production but also to
prevent excessive CO2 in the media which can impact these critical performance endpoints[3]
[3] Marks, D.M. (2003). Equipment design considerations for large scale cell culture. Cytotechnology 42:21-33
01
02
03
Agenda
13
General Principles
Key Engineering Parameters – Scaling
Strategies
Application to the Mobius® Bioreactors
from 2 L to 2000 L
Scaling Strategies with Stirred Single-use Bioreactors
Application to the Mobius® Bioreactors from 2 L to 2000 L
Parameters that can be used for scale-up include:
✓ Geometric similarity – Impeller Design
✓ Mixing Time - Reynolds Number
✓ Tip speed (~ shear)
✓ Power input per volume (P/V)
✓ Oxygen mass transfer coefficient (kLa)
Ratio
Working Volume : Total Volume 0.8 0.8 0.8 0.8 0.8
Impeller Diameter : Vessel Diam. 0.6 0.3 0.3 0.3 0.3
Vessel Height : Vessel Diameter 1.8:1 2.0:1 2.0:1 2.0:1 2.0:1
Liquid Height : Vessel Diameter 1.4:1 1.7:1 1.6:1 1.6:1 1.6:1
Dual sparger (open pipe/micro or ring) YES YES YES YES YES
Min – Max Working Volume (L) 1 – 2.4 10 – 50 40 – 200 200 - 1000 400 – 2000
Mobius® Bioreactor Portfolio Overview:
Scalable from 3 L to 2000 L
2,000 L1,000 L200 L50 L3 L
5:1 turn down ratio
Mobius® Single-Use Bioreactor Platform
Mobius® 3 L Bioreactor as a Reliable Scale-Down Model
Probes
• Electrochemical probes
• Sterile insertion in the hood
2 spargers
• Open pipe
• Microsparger
Sampling and Additions
• Addition lines with check valves
• Weldable open pipe for flexibility
Low Shear Marine Scoping Impeller
All weldable C-Flex® tubing
Working volumes
1 L – 2.4 L
Mobius® Single-Use Bioreactor
Hardware: Mobius® 50 L & 200 L Bioreactor
Bioreactor Tank
• Fully Jacketed Tank
• Double doors
• Window for visibility
Mobius® SensorReady
Monitoring & Sampling Loop
2 to 8 sensors. No change in
bag design.
Vent Heater
• Primary & back-up highly
hydrophobic Aervent® XL5 filters for
added security
Impeller
• Levitating impeller
• Bottom-mounted for
large operating range
(20% to 100%)
Spargers
• Open pipe
• Microsparger or Ringsparger
(CO2 stripping & O2)
40 L
200 L
HMI
MFCs
Pumps
Mobius® Single-Use Bioreactor Platform
Hardware: 1000 L and 2000 L Mobius® Bioreactor
without vent filters :
2.56 m / 3.03 m
with vent filters :
3.00 m / 3.48 m
Integrated
software and
automation
Open drawer for
easy Flexware®
assembly install &
removal
Door with wide sight
glass
Visual monitoring
of the culture
Parameters that can be used for scale-up include:
✓ Geometric similarity – Impeller Design
✓ Mixing Time - Reynolds Number
✓ Tip speed (~ shear)
✓ Power input per volume (P/V)
✓ Oxygen mass transfer coefficient (kLa)
Scaling Strategies with Stirred Single-use Bioreactors
Application to the Mobius® Bioreactors from 2 L to 2000 L
0
20
40
60
80
100
120
140
0 5 10 15 20 25
MixingTime,seconds
Power Input, W/m3
Scalability of Mixing (conductivity)
3 L
50 L
200 L
1000 L
2000 L
Scaling Strategies with Stirred Single-use Bioreactors
Mixing in Mobius® Bioreactors
 Method using conductivity
 Fast and homogeneous mixing is
achieved across the scales, at low
power input
 Importance of the internal baffle
Scaling Strategies with Stirred Single-use Bioreactors
Mixing in Mobius® Bioreactors: Importance of the Internal Baffle
With
Baffle
Without
Baffle
Mixing
completed
Parameters that can be used for scale-up include:
✓ Geometric similarity – Impeller Design
✓ Mixing Time - Reynolds Number
✓ Tip speed (~ shear)
✓ Power input per volume (P/V)
✓ Oxygen mass transfer coefficient (kLa)
Scaling Strategies with Stirred Single-use Bioreactors
Application to the Mobius® Bioreactors from 2 L to 2000 L
Scaling Strategies with Stirred Single-use Bioreactors
Power / Volume – Tip Speed – Reynolds Number – Mobius® Bioreactors
Bioreactor W/m3 RPM
Tip Speed
(m/s)
Re
3 L
(Np =
0.3)
1 82 0.3 8,890
10 178 0.7 19,297
20 224 0.9 24,284
50 L
(Np =
3.2)
1 61 0.3 13,397
10 131 0.7 28,771
20 165 0.9 36,238
200 L
(Np =
4.0)
1 38 0.4 23,728
10 81 0.8 50,579
20 102 1.0 63,692
1000 L
(Np = 3.5)
1 33 0.5 48,097
10 72 1.1
104,940
20 90 1.3
131,174
2000 L
(Np =
3.3)
1 33 0.6 67,177
10 70 1.2
142,497
20 87 1.5
177,104
0
20
40
60
80
100
120
0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8
Power/Volume(W/m^3)
Tip Speed (m/s)
3 L 50 L 200 L 1000 L 2000 L
Parameters that can be used for scale-up include:
✓ Geometric similarity – Impeller Design
✓ Mixing Time - Reynolds Number
✓ Tip speed (~ shear)
✓ Power input per volume (P/V)
✓ Oxygen mass transfer coefficient (kLa)
Scaling Strategies with Stirred Single-use Bioreactors
Application to the Mobius® Bioreactors from 2 L to 2000 L
Case Study
Oxygen Mass Transfer
Constant parameters
P/V kLa
+
P/V vvm
+
Non constant parameters
kLa
vvm
Impossible to maintain P/V, vvm and kLa constant between scales
(impact on oxygenation and pCO2)
2000 L
200 L
50 L3 L
P Value < 0,05
R² within specification
KLa = f (P/V ; Vs)
ANOVA
Validation
Oxygen Mass Transfer
Case study
KLa or VVM?
Proof of Concept: Comparison of two scale-up strategies
Oxygen Mass Transfer
27
Case study
Proof of Concept: Comparison of two scale-up strategies
Oxygen Mass Transfer
28
Mobius® 3 L Bioreactor
Wv = 2,197 L
Mobius® 200 L Bioreactor
Wv = 188 L
Stirring = 180 rpm
Pug = 9,39 W/m3
Stirring = 80 rpm
Pug = 10,29 W/m3
Gas = 75 mL/min
KLa = 6,07 hr-1
Gas = 5 (7,5) L/min
KLa = 24,66 (31,8) hr-1
O2
(gas)
O2
(gas)
VVM Approach
Case study
Proof of Concept: Comparison of two scale-up strategies
Oxygen Mass Transfer
29
Mobius® 3 L Bioreactor
Wv = 2,1 L
Mobius® 200 L Bioreactor
Wv = 180,4 L
Stirring = 180 rpm
Pug = 9,93 W/m3
Stirring = 78 rpm
Pug = 9,94 W/m3
Gas = 75 mL/min
KLa = 6,15 hr-1
Gas = 1,64L/min
KLa = 6,24 hr-1
O2
(gas)
O2
(gas)
KLa Approach
Case study
Oxygen Mass Transfer
Constant KLa Constant VVM
Similar VCD & viability profile for both scale-up strategy (not shown)
Same profile for the specific productivity (not shown) with constant kLa approach (3 L=200 L)
Final titer for kLa strategy more in line with the small scale
Case study
Oxygen Mass Transfer
Constant kLa
(4,39 to 6,30 h-1)
Constant VVM
(kLa : 28,18 to 28,79 h-1)1
2
1 2
The scale-up strategy with constant kLa is a successful new approach
-Better DO control (SP) with the kLa strategy
-Maximum O2 injection at 1,64L/min (VS 5-7,5L/min)
Example of O2 injection at maximum VCD (PD8)
Case study
Oxygen Mass Transfer
Similar specific
productivity
compared to the
reference scale
Lower 02 flow needed
(1,64L/min
instead of 5 to 7,5L/min)
at 200 L
HCD CHO
High VCD
High O2
consumption
New scale-up
strategy:
Constant kLa
Successful
Proof of concept
Case study
Cell Culture Performances with P/V as Scaling Factor
mAb Production with CHO-S Cell Line
2000 L
3 L
200 L
CONCLUSION
Scaling Strategies with Stirred Single-use Bioreactors
 Scalability of the Mobius® Bioreactor Platform demonstrated from 2 L to 2000 L
 Power per volume is a relevant scaling factor combined with kLa
 Knowledge and experience are nearly as important as the scaling parameters:
You know your cells, we know the process with Mobius® Bioreactors.
Collaboration is key for success!
References :
Odeleye et al 3L Cellready fluid dynamics Chem E Science 2014
Xing, Z. (2009). Scale-up Analysis of a CHO Cell Culture Process in Large-Scale Bioreactors. Biotechnology and Bioengineering 103:733-746.
Kaiser, S.D. et al, (2011) CFD for Characterizing Standard and Single-use Stirred Cell Culture Bioreactors. In Computational Fluid Dynamics Technologies and Applications, InTech
Marks, D.M. (2003). Equipment design considerations for large scale cell culture. Cytotechnology 42:21-33.
A-mab, a case study in Bioprocess Development, CMC Biotech working group 2009
Schedule an in-person or remote
visit today.
MerckMillipore.com/mlab
The vibrant M, Aervent, Flexware, M Lab, Mobius are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of
their respective owners. Detailed information on trademarks is available via publicly accessible resources.
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

More Related Content

What's hot

Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Merck Life Sciences
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...Merck Life Sciences
 
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...KBI Biopharma
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)MilliporeSigma
 
Single use technology: a regulatory perspective
Single use technology: a regulatory perspectiveSingle use technology: a regulatory perspective
Single use technology: a regulatory perspectiveTGA Australia
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Merck Life Sciences
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Merck Life Sciences
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...MilliporeSigma
 
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Merck Life Sciences
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingMerck Life Sciences
 
Continuous Manufacturing of Tablets
Continuous Manufacturing of TabletsContinuous Manufacturing of Tablets
Continuous Manufacturing of TabletsYash Nandwani
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeMilliporeSigma
 
High concentration uf formulation challenges &amp; mitigation strategies by s...
High concentration uf formulation challenges &amp; mitigation strategies by s...High concentration uf formulation challenges &amp; mitigation strategies by s...
High concentration uf formulation challenges &amp; mitigation strategies by s...Merck Life Sciences
 
Continuous Manufacturing - Issues and Answers
Continuous Manufacturing - Issues and AnswersContinuous Manufacturing - Issues and Answers
Continuous Manufacturing - Issues and AnswersMilliporeSigma
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...MilliporeSigma
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngMilliporeSigma
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos ootAMOGH DANDEKAR
 
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...MilliporeSigma
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMilliporeSigma
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterMilliporeSigma
 

What's hot (20)

Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
 
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
 
Single use technology: a regulatory perspective
Single use technology: a regulatory perspectiveSingle use technology: a regulatory perspective
Single use technology: a regulatory perspective
 
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
Modern BioManufacturing: Single-Use Technologies in Configurable, Prefabricat...
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
 
Continuous Manufacturing of Tablets
Continuous Manufacturing of TabletsContinuous Manufacturing of Tablets
Continuous Manufacturing of Tablets
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
 
High concentration uf formulation challenges &amp; mitigation strategies by s...
High concentration uf formulation challenges &amp; mitigation strategies by s...High concentration uf formulation challenges &amp; mitigation strategies by s...
High concentration uf formulation challenges &amp; mitigation strategies by s...
 
Continuous Manufacturing - Issues and Answers
Continuous Manufacturing - Issues and AnswersContinuous Manufacturing - Issues and Answers
Continuous Manufacturing - Issues and Answers
 
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
Optimization of Tangential Flow Filtration Applications and Scale Up Consider...
 
Setting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund AngSetting up for successful lot release testing by Edmund Ang
Setting up for successful lot release testing by Edmund Ang
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
Upcoming USP 665 - Level of Characterization of Single-Use Systems Today and ...
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
 

Similar to Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical Scale

Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...KBI Biopharma
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...KBI Biopharma
 
Preliminary Development of Mini-fluidic OFR Technology
Preliminary Development of Mini-fluidic OFR TechnologyPreliminary Development of Mini-fluidic OFR Technology
Preliminary Development of Mini-fluidic OFR TechnologyKirubanandan Shanmugam
 
L-paper_pulp_mill_case study-ppt (1).ppt
L-paper_pulp_mill_case study-ppt (1).pptL-paper_pulp_mill_case study-ppt (1).ppt
L-paper_pulp_mill_case study-ppt (1).pptnehasolanki83
 
sewer treatment proposal.pptx
sewer treatment proposal.pptxsewer treatment proposal.pptx
sewer treatment proposal.pptxThushan9
 
IRJET- Characterisation of Grey Water and Treatment using Moving Bed Biof...
IRJET-  	  Characterisation of Grey Water and Treatment using Moving Bed Biof...IRJET-  	  Characterisation of Grey Water and Treatment using Moving Bed Biof...
IRJET- Characterisation of Grey Water and Treatment using Moving Bed Biof...IRJET Journal
 
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...IRJET Journal
 
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel Cell
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel CellDairy Wastewater Treatment and Electricity Generation using Microbial Fuel Cell
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel CellIRJET Journal
 
Computational fluid dynamics
Computational fluid dynamicsComputational fluid dynamics
Computational fluid dynamicsZeeshan Inamdar
 
IRJET- Performance Evolution of different MBBR Media in Waste Water Treatm...
IRJET- 	  Performance Evolution of different MBBR Media in Waste Water Treatm...IRJET- 	  Performance Evolution of different MBBR Media in Waste Water Treatm...
IRJET- Performance Evolution of different MBBR Media in Waste Water Treatm...IRJET Journal
 
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONS
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONSDIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONS
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONSiQHub
 
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...IRJET Journal
 
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...IRJET Journal
 
The influence of mixing in the process
The influence of mixing in the processThe influence of mixing in the process
The influence of mixing in the processAldo Shusterman
 
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...IRJET Journal
 
Presentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalPresentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalManuel Hidalgo
 
Presentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalPresentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalManuel Hidalgo
 

Similar to Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical Scale (20)

Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-use Bioreactor Platform for Biopharmaceutical Manufac...
 
Mbbr
MbbrMbbr
Mbbr
 
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
Establishing Improved O2 Supply, Lower dCO2 Built Up and pH Control in Large ...
 
Etp 2011 -slide share
Etp 2011 -slide shareEtp 2011 -slide share
Etp 2011 -slide share
 
Preliminary Development of Mini-fluidic OFR Technology
Preliminary Development of Mini-fluidic OFR TechnologyPreliminary Development of Mini-fluidic OFR Technology
Preliminary Development of Mini-fluidic OFR Technology
 
L-paper_pulp_mill_case study-ppt (1).ppt
L-paper_pulp_mill_case study-ppt (1).pptL-paper_pulp_mill_case study-ppt (1).ppt
L-paper_pulp_mill_case study-ppt (1).ppt
 
sewer treatment proposal.pptx
sewer treatment proposal.pptxsewer treatment proposal.pptx
sewer treatment proposal.pptx
 
Chemtronics Green STP AD+
Chemtronics  Green STP AD+Chemtronics  Green STP AD+
Chemtronics Green STP AD+
 
IRJET- Characterisation of Grey Water and Treatment using Moving Bed Biof...
IRJET-  	  Characterisation of Grey Water and Treatment using Moving Bed Biof...IRJET-  	  Characterisation of Grey Water and Treatment using Moving Bed Biof...
IRJET- Characterisation of Grey Water and Treatment using Moving Bed Biof...
 
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...
IRJET- Applications of Anaerobic Baffled Reactor in Wastewater Treatment usin...
 
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel Cell
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel CellDairy Wastewater Treatment and Electricity Generation using Microbial Fuel Cell
Dairy Wastewater Treatment and Electricity Generation using Microbial Fuel Cell
 
Computational fluid dynamics
Computational fluid dynamicsComputational fluid dynamics
Computational fluid dynamics
 
IRJET- Performance Evolution of different MBBR Media in Waste Water Treatm...
IRJET- 	  Performance Evolution of different MBBR Media in Waste Water Treatm...IRJET- 	  Performance Evolution of different MBBR Media in Waste Water Treatm...
IRJET- Performance Evolution of different MBBR Media in Waste Water Treatm...
 
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONS
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONSDIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONS
DIGITAL TWIN TO AUTOMATE OPTIMISATION AND EMBED EXCELLENCE IN WWTP OPERATIONS
 
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
 
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
Designing of Sewage Treatment Plant for Society Level By using Sequential Bat...
 
The influence of mixing in the process
The influence of mixing in the processThe influence of mixing in the process
The influence of mixing in the process
 
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...
Rotating Biological Contactor Wastewater Treatment Using Banana Leaves for Gr...
 
Presentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalPresentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-final
 
Presentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-finalPresentation-Symwatech-WED-05.06.16-final
Presentation-Symwatech-WED-05.06.16-final
 

More from Merck Life Sciences

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeMerck Life Sciences
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...Merck Life Sciences
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationMerck Life Sciences
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...Merck Life Sciences
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Merck Life Sciences
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...Merck Life Sciences
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsMerck Life Sciences
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Merck Life Sciences
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesMerck Life Sciences
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Merck Life Sciences
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...Merck Life Sciences
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Merck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Merck Life Sciences
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Merck Life Sciences
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsMerck Life Sciences
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Merck Life Sciences
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...Merck Life Sciences
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...Merck Life Sciences
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesMerck Life Sciences
 

More from Merck Life Sciences (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliHigh Profile Call Girls Chandigarh Aarushi
 
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...High Profile Call Girls Chandigarh Aarushi
 
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabad
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service HyderabadCall Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabad
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabaddelhimodelshub1
 
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service GoaRussian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goanarwatsonia7
 
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service HyderabadCall Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabaddelhimodelshub1
 
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersHi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availablesandeepkumar69420
 
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call Now
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call NowKukatpally Call Girls Services 9907093804 High Class Babes Here Call Now
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call NowHyderabad Call Girls Services
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girls Service Gurgaon
 
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...ggsonu500
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...Vip call girls In Chandigarh
 
Call Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any TimeCall Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any Timedelhimodelshub1
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
Call Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any TimeCall Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any Timedelhimodelshub1
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Timedelhimodelshub1
 
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...ggsonu500
 
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabad
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service HyderabadCall Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabad
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabaddelhimodelshub1
 

Recently uploaded (20)

Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service MohaliCall Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
 
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
Call Girls Service Chandigarh Grishma ❤️🍑 9907093804 👄🫦 Independent Escort Se...
 
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabad
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service HyderabadCall Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabad
Call Girls in Hyderabad Lavanya 9907093804 Independent Escort Service Hyderabad
 
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service GoaRussian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
Russian Call Girls in Goa Samaira 7001305949 Independent Escort Service Goa
 
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service HyderabadCall Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabad
Call Girls Hyderabad Kirti 9907093804 Independent Escort Service Hyderabad
 
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Subhash Nagar Delhi reach out to us at 🔝9953056974🔝
 
Russian Call Girls South Delhi 9711199171 discount on your booking
Russian Call Girls South Delhi 9711199171 discount on your bookingRussian Call Girls South Delhi 9711199171 discount on your booking
Russian Call Girls South Delhi 9711199171 discount on your booking
 
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbersHi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
Hi,Fi Call Girl In Marathahalli - 7001305949 with real photos and phone numbers
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service available
 
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service GuwahatiCall Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
 
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call Now
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call NowKukatpally Call Girls Services 9907093804 High Class Babes Here Call Now
Kukatpally Call Girls Services 9907093804 High Class Babes Here Call Now
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
 
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 68 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...No Advance 9053900678 Chandigarh  Call Girls , Indian Call Girls  For Full Ni...
No Advance 9053900678 Chandigarh Call Girls , Indian Call Girls For Full Ni...
 
Call Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any TimeCall Girls Uppal 7001305949 all area service COD available Any Time
Call Girls Uppal 7001305949 all area service COD available Any Time
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
Call Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any TimeCall Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any Time
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Time
 
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabad
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service HyderabadCall Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabad
Call Girl Hyderabad Madhuri 9907093804 Independent Escort Service Hyderabad
 

Scaling Strategies with Stirred Single-Use Bioreactors from Bench to Clinical Scale

  • 1. Merck KGaA Darmstadt, Germany Lenaig Savary, Senior Biomanufacturing Engineer Scaling Strategies with stirred single-use bioreactors from bench to clinical scale Application to Mobius® Bioreactors from 2 L to 2000 L
  • 2. 01 02 03 Agenda 2 General Principles Key Engineering Parameters – Scaling Strategies Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 3. Scaling Strategies with Stirred Single-use Bioreactors No Linear Factors in Scaling Up As surface area increases, process volume and process complexity also increase. Surface Area Single Cell Shake Flask Bioreactor Complexity
  • 4. Scale-up General Principles Influencing Factors Biological Factors Chemical Factors Physical Factors Number of generations Mutation probability Contamination vulnerability pH control agents Medium quality Water quality Medium sterilization Foam formation due to surface tension changes Tank configuration Aeration (O2 supply, CO2 stripping, shear stress) Agitation (homogenization and shear stress) Back pressure and hydrostatic pressure Temperature control and heat transfer Reference: M. Levin. Pharmaceutical Process Scale Up. 2nd Edition Taylor & Francis 2006
  • 5. Scale-Up and Process Transfer General Principles Agitation and aeration ▪ Bulk liquid mixing and shear stress → Agitation ▪ Oxygen transfer and pCO2 removal → Aeration Parameters that can be used for scale-up include: • Geometric similarity—impeller design • Mixing time—Reynolds number • Tip speed (~ shear) • Power input per volume (P/V) • Oxygen mass transfer coefficient (kLa) Ensuring circulation of nutrients, dissolved gasses and removing metabolites is important in bioreactors The most important criteria is mixing. Mixing is more difficult as scale increases.
  • 6. Scaling Strategies with Single-use STR Impossible to Keep All Scale-up Criteria Constant Mixing time Tip speed (shear stress) Power input per volume (P/V) Oxygen mass transfer coefficient KLa Geometric similarity It is critical to characterize key engineering parameters and identify a relevant scaling factor according to bioreactor design.
  • 7. 01 02 03 Agenda 7 General Principles Key Engineering Parameters – Scaling Strategies Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 8.  Vessel height to vessel diameter (H/D) typically between 1:1 and 2:1  Impeller diameter to vessel diameter (Dimp/D) 50 L 200 L H D Dimp 1000 L3 L Keeping constant ratio in dimension of bioreactors across the scales Geometric Similarity Scaling Strategies with Stirred Single-use Bioreactors
  • 9. Reynolds Number Dimensionless number to predict flow patterns in turbulent conditions = Re > 10,000 Why is mixing a critical parameter ?  Even distribution of nutrients,  Minimizing waste concentration,  Control of pH, DO and Temperature,  Minimizing shear stress (impeller / fluid dynamics)  Proper mixing is more challenging at larger scales than smaller scales Scaling Strategies with Stirred Single-use Bioreactors Mixing Time and Reynolds Number 𝑹𝒆 = 𝝆𝑵𝑫 𝟐 𝝁 Where ρ = Fluid density N = Impeller agitation Rate D = Impeller diameter μ = Fluid dynamic viscosity  Based on a cylindrical tank design with centered rotating impeller  Does not take into account impeller design Mixing Times: compare like for like ! Mixing time is empirically determined by the decolorization method or the conductivity method Laminar flow Re < 10 Transition field 10 < re < 104 Turbulent flow 104 < Re
  • 10. Scaling Strategies with Stirred Single-use Bioreactors Tip Speed (m/s) ▪ Criteria for shear force is typically 2 m/s maximum. ▪ The highest shear zones in a stirred-tank bioreactor are often described as existing within the impeller zone. Because the outer edges of the impeller blades create shear as they rotate through the liquid, the impeller tip speed is often considered during bioreactor comparisons: 𝑻𝒊𝒑 𝑺𝒑𝒆𝒆𝒅 = 𝝅 ∙ 𝑫 ∙ 𝑵 Where D = Impeller diameter N = Impeller agitation rate 0.000 0.200 0.400 0.600 0.800 1.000 1.200 1.400 1.600 1.800 20 40 60 80 100120140160180200220240260280300320340360380400 TipSpeed(m/s) RPM Mobius® Bioreactor Tip Speed Calculations 3L CellReady 50L CellReady 200L CellReady Tip speed calculation does not take into account impeller design. 3 L 50 L 200 L
  • 11. Power Input per Volume (P/V) Scaling Strategies with Stirred Single-use Bioreactors 𝑃𝑜 𝑉 = 𝑁 𝑃 ∙ 𝜌 ∙ 𝑁3 ∙ 𝐷5 Where Po = Ungassed power input V = Liquid working volume Np = Impeller power number ρ = Fluid density N = Impeller agitation rate D = Impeller diameter 200 L Mobius® Bioreactor with bottom-mounted impeller Choosing an agitation rate that matches energy dissipation rate or power per unit volume (W/m3) is a common approach. Impeller design, fluid density, and agitation rate are considered in the ungassed power per unit volume (Po/V) equation Reference: Xing Zizhuo et al. Biotechnology and Bioengineering, Vol 103, 2009. Stephen Kaiser et al. Computational Fluid Dynamics Technologies and Applications, InTech, 2011 Using this scaling method, agitation rate is varied to maintain similar ungassed power per unit volume across vessels and working volumes. 40 L 200 L Easy calculation of P/V Power Input Per Volume (P/V)  Working volume range  Impeller always immersed
  • 12. Scaling Strategies with Single-use STR Oxygen Mass Transfer Coefficient (kLa) and Oxygen Uptake Rate  Physical kLa are determined for various Power/Volume (P/V) and gas flow rates (vvm) using the static gassing out method: kLa = Oxygen Transfer Rate / DO saturation concentration = OTR/C*  Biological kLa depends on the clone and maximum viable cell concentration : kLa BIO = Oxygen Uptake Rate / DO saturation concentration = OURmax/C*=(QO2 max). VCCmax /C* • A-mAb case study[4] at 15.106 cells/mL with OUR of 1.5 mmol/L.h → kLa = 7 h-1  Typical kLa for animal cell culture below 20.106 cells/mL : 1-10 h-1 Not always known! To prevent hypoxia (oxygen limitation), available kLa for a bioreactor design should be superior to the biological kLa demand of cell lines in culture. kLa > kLa BIO [4] A-mab, a case study in Bioprocess Development, CMC Biotech working group 2009 Sufficient O2/Air delivery is required not only to support cell growth, metabolism and protein production but also to prevent excessive CO2 in the media which can impact these critical performance endpoints[3] [3] Marks, D.M. (2003). Equipment design considerations for large scale cell culture. Cytotechnology 42:21-33
  • 13. 01 02 03 Agenda 13 General Principles Key Engineering Parameters – Scaling Strategies Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 14. Scaling Strategies with Stirred Single-use Bioreactors Application to the Mobius® Bioreactors from 2 L to 2000 L Parameters that can be used for scale-up include: ✓ Geometric similarity – Impeller Design ✓ Mixing Time - Reynolds Number ✓ Tip speed (~ shear) ✓ Power input per volume (P/V) ✓ Oxygen mass transfer coefficient (kLa)
  • 15. Ratio Working Volume : Total Volume 0.8 0.8 0.8 0.8 0.8 Impeller Diameter : Vessel Diam. 0.6 0.3 0.3 0.3 0.3 Vessel Height : Vessel Diameter 1.8:1 2.0:1 2.0:1 2.0:1 2.0:1 Liquid Height : Vessel Diameter 1.4:1 1.7:1 1.6:1 1.6:1 1.6:1 Dual sparger (open pipe/micro or ring) YES YES YES YES YES Min – Max Working Volume (L) 1 – 2.4 10 – 50 40 – 200 200 - 1000 400 – 2000 Mobius® Bioreactor Portfolio Overview: Scalable from 3 L to 2000 L 2,000 L1,000 L200 L50 L3 L 5:1 turn down ratio
  • 16. Mobius® Single-Use Bioreactor Platform Mobius® 3 L Bioreactor as a Reliable Scale-Down Model Probes • Electrochemical probes • Sterile insertion in the hood 2 spargers • Open pipe • Microsparger Sampling and Additions • Addition lines with check valves • Weldable open pipe for flexibility Low Shear Marine Scoping Impeller All weldable C-Flex® tubing Working volumes 1 L – 2.4 L
  • 17. Mobius® Single-Use Bioreactor Hardware: Mobius® 50 L & 200 L Bioreactor Bioreactor Tank • Fully Jacketed Tank • Double doors • Window for visibility Mobius® SensorReady Monitoring & Sampling Loop 2 to 8 sensors. No change in bag design. Vent Heater • Primary & back-up highly hydrophobic Aervent® XL5 filters for added security Impeller • Levitating impeller • Bottom-mounted for large operating range (20% to 100%) Spargers • Open pipe • Microsparger or Ringsparger (CO2 stripping & O2) 40 L 200 L HMI MFCs Pumps
  • 18. Mobius® Single-Use Bioreactor Platform Hardware: 1000 L and 2000 L Mobius® Bioreactor without vent filters : 2.56 m / 3.03 m with vent filters : 3.00 m / 3.48 m Integrated software and automation Open drawer for easy Flexware® assembly install & removal Door with wide sight glass Visual monitoring of the culture
  • 19. Parameters that can be used for scale-up include: ✓ Geometric similarity – Impeller Design ✓ Mixing Time - Reynolds Number ✓ Tip speed (~ shear) ✓ Power input per volume (P/V) ✓ Oxygen mass transfer coefficient (kLa) Scaling Strategies with Stirred Single-use Bioreactors Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 20. 0 20 40 60 80 100 120 140 0 5 10 15 20 25 MixingTime,seconds Power Input, W/m3 Scalability of Mixing (conductivity) 3 L 50 L 200 L 1000 L 2000 L Scaling Strategies with Stirred Single-use Bioreactors Mixing in Mobius® Bioreactors  Method using conductivity  Fast and homogeneous mixing is achieved across the scales, at low power input  Importance of the internal baffle
  • 21. Scaling Strategies with Stirred Single-use Bioreactors Mixing in Mobius® Bioreactors: Importance of the Internal Baffle With Baffle Without Baffle Mixing completed
  • 22. Parameters that can be used for scale-up include: ✓ Geometric similarity – Impeller Design ✓ Mixing Time - Reynolds Number ✓ Tip speed (~ shear) ✓ Power input per volume (P/V) ✓ Oxygen mass transfer coefficient (kLa) Scaling Strategies with Stirred Single-use Bioreactors Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 23. Scaling Strategies with Stirred Single-use Bioreactors Power / Volume – Tip Speed – Reynolds Number – Mobius® Bioreactors Bioreactor W/m3 RPM Tip Speed (m/s) Re 3 L (Np = 0.3) 1 82 0.3 8,890 10 178 0.7 19,297 20 224 0.9 24,284 50 L (Np = 3.2) 1 61 0.3 13,397 10 131 0.7 28,771 20 165 0.9 36,238 200 L (Np = 4.0) 1 38 0.4 23,728 10 81 0.8 50,579 20 102 1.0 63,692 1000 L (Np = 3.5) 1 33 0.5 48,097 10 72 1.1 104,940 20 90 1.3 131,174 2000 L (Np = 3.3) 1 33 0.6 67,177 10 70 1.2 142,497 20 87 1.5 177,104 0 20 40 60 80 100 120 0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 Power/Volume(W/m^3) Tip Speed (m/s) 3 L 50 L 200 L 1000 L 2000 L
  • 24. Parameters that can be used for scale-up include: ✓ Geometric similarity – Impeller Design ✓ Mixing Time - Reynolds Number ✓ Tip speed (~ shear) ✓ Power input per volume (P/V) ✓ Oxygen mass transfer coefficient (kLa) Scaling Strategies with Stirred Single-use Bioreactors Application to the Mobius® Bioreactors from 2 L to 2000 L
  • 25. Case Study Oxygen Mass Transfer Constant parameters P/V kLa + P/V vvm + Non constant parameters kLa vvm Impossible to maintain P/V, vvm and kLa constant between scales (impact on oxygenation and pCO2)
  • 26. 2000 L 200 L 50 L3 L P Value < 0,05 R² within specification KLa = f (P/V ; Vs) ANOVA Validation Oxygen Mass Transfer Case study
  • 27. KLa or VVM? Proof of Concept: Comparison of two scale-up strategies Oxygen Mass Transfer 27 Case study
  • 28. Proof of Concept: Comparison of two scale-up strategies Oxygen Mass Transfer 28 Mobius® 3 L Bioreactor Wv = 2,197 L Mobius® 200 L Bioreactor Wv = 188 L Stirring = 180 rpm Pug = 9,39 W/m3 Stirring = 80 rpm Pug = 10,29 W/m3 Gas = 75 mL/min KLa = 6,07 hr-1 Gas = 5 (7,5) L/min KLa = 24,66 (31,8) hr-1 O2 (gas) O2 (gas) VVM Approach Case study
  • 29. Proof of Concept: Comparison of two scale-up strategies Oxygen Mass Transfer 29 Mobius® 3 L Bioreactor Wv = 2,1 L Mobius® 200 L Bioreactor Wv = 180,4 L Stirring = 180 rpm Pug = 9,93 W/m3 Stirring = 78 rpm Pug = 9,94 W/m3 Gas = 75 mL/min KLa = 6,15 hr-1 Gas = 1,64L/min KLa = 6,24 hr-1 O2 (gas) O2 (gas) KLa Approach Case study
  • 30. Oxygen Mass Transfer Constant KLa Constant VVM Similar VCD & viability profile for both scale-up strategy (not shown) Same profile for the specific productivity (not shown) with constant kLa approach (3 L=200 L) Final titer for kLa strategy more in line with the small scale Case study
  • 31. Oxygen Mass Transfer Constant kLa (4,39 to 6,30 h-1) Constant VVM (kLa : 28,18 to 28,79 h-1)1 2 1 2 The scale-up strategy with constant kLa is a successful new approach -Better DO control (SP) with the kLa strategy -Maximum O2 injection at 1,64L/min (VS 5-7,5L/min) Example of O2 injection at maximum VCD (PD8) Case study
  • 32. Oxygen Mass Transfer Similar specific productivity compared to the reference scale Lower 02 flow needed (1,64L/min instead of 5 to 7,5L/min) at 200 L HCD CHO High VCD High O2 consumption New scale-up strategy: Constant kLa Successful Proof of concept Case study
  • 33. Cell Culture Performances with P/V as Scaling Factor mAb Production with CHO-S Cell Line 2000 L 3 L 200 L
  • 34. CONCLUSION Scaling Strategies with Stirred Single-use Bioreactors  Scalability of the Mobius® Bioreactor Platform demonstrated from 2 L to 2000 L  Power per volume is a relevant scaling factor combined with kLa  Knowledge and experience are nearly as important as the scaling parameters: You know your cells, we know the process with Mobius® Bioreactors. Collaboration is key for success! References : Odeleye et al 3L Cellready fluid dynamics Chem E Science 2014 Xing, Z. (2009). Scale-up Analysis of a CHO Cell Culture Process in Large-Scale Bioreactors. Biotechnology and Bioengineering 103:733-746. Kaiser, S.D. et al, (2011) CFD for Characterizing Standard and Single-use Stirred Cell Culture Bioreactors. In Computational Fluid Dynamics Technologies and Applications, InTech Marks, D.M. (2003). Equipment design considerations for large scale cell culture. Cytotechnology 42:21-33. A-mab, a case study in Bioprocess Development, CMC Biotech working group 2009
  • 35. Schedule an in-person or remote visit today. MerckMillipore.com/mlab
  • 36. The vibrant M, Aervent, Flexware, M Lab, Mobius are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.